Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)

Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)

ABSTRACTTo understand SARS-CoV-2 immunity after natural infection or vaccination, functional assays such as virus neutralising assays are needed. So far, assays to detect SARS-CoV-2 neutralising antibodies rely on cell-culture based infection assays either using wild type SARS-CoV-2 or pseudotyped v...

Full description

Bibliographic Details
Main Authors: Benjamin Meyer, Johan Reimerink, Giulia Torriani, Fion Brouwer, Gert-Jan Godeke, Sabine Yerly, Marieke Hoogerwerf, Nicolas Vuilleumier, Laurent Kaiser, Isabella Eckerle, Chantal Reusken
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Emerging Microbes and Infections
Subjects:
SARS-CoV-2
neutralising antibodies
surrogate virus neutralisation assay
pseudovirus neutralisation assay
cell-based virus neutralisation assay
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2020.1835448

Internet

https://www.tandfonline.com/doi/10.1080/22221751.2020.1835448

Similar Items